Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Clinical trial NCT00306995 · COMPLETED

Trial details

NCT number: NCT00306995
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Influenza Vaccines

Start date: 2005-05-11
Primary completion: 2006-07-04
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.